Abstract
Pompe disease is a lysosomal storage disorder caused by acid α-glucosidase deficiency and characterized by progressive muscle weakness. Enzyme replacement therapy (ERT) has ameliorated patients' perspectives, but reversal of skeletal muscle pathology remains a challenge. We studied pretreatment biopsies of 22 patients with different phenotypes to investigate to what extent fiber-type distribution and fiber-type-specific damage contribute to clinical diversity. Pompe patients have the same fiber-type distribution as healthy persons, but among nonclassic patients with the same GAA mutation (c.-32-13T>G), those with early onset of symptoms tend to have more type 2 muscle fibers than those with late-onset disease. Further, it seemed that the older, more severely affected classic infantile patients and the wheelchair-bound and ventilated nonclassic patients had a greater proportion of type 2x muscle fibers. However, as in other diseases, this may be caused by physical inactivity of those patients. © 2012 SSIEM and Springer Science+Business Media Dordrecht.
Cite
CITATION STYLE
Van Den Berg, L. E. M., Drost, M. R., Schaart, G., De Laat, J., Van Doorn, P. A., Van Der Ploeg, A. T., & Reuser, A. J. J. (2013). Muscle fiber-type distribution, fiber-type-specific damage, and the Pompe disease phenotype. Journal of Inherited Metabolic Disease, 36(5), 787–794. https://doi.org/10.1007/s10545-012-9541-7
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.